Literature DB >> 23613131

The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A 2A receptors.

Manuella P Kaster1, Josiane Budni, Marta Gazal, Mauricio P Cunha, Adair R S Santos, Ana Lúcia S Rodrigues.   

Abstract

Inosine is an endogenous purine nucleoside, which is formed during the breakdown of adenosine. The adenosinergic system was already described as capable of modulating mood in preclinical models; we now explored the effects of inosine in two predictive models of depression: the forced swim test (FST) and tail suspension test (TST). Mice treated with inosine displayed higher anti-immobility in the FST (5 and 50 mg/kg, intraperitoneal route (i.p.)) and in the TST (1 and 10 mg/kg, i.p.) when compared to vehicle-treated groups. These antidepressant-like effects started 30 min and lasted for 2 h after intraperitoneal administration of inosine and were not accompanied by any changes in the ambulatory activity in the open-field test. Both adenosine A1 and A2A receptor antagonists prevented the antidepressant-like effect of inosine in the FST. In addition, the administration of an adenosine deaminase inhibitor (1 and 10 mg/kg, i.p.) also caused an antidepressant-like effect in the FST. These results indicate that inosine possesses an antidepressant-like effect in the FST and TST probably through the activation of adenosine A1 and A2A receptors, further reinforcing the potential of targeting the purinergic system to the management of mood disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23613131      PMCID: PMC3757140          DOI: 10.1007/s11302-013-9361-8

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  40 in total

1.  Uptake and utilization of nucleosides for energy repletion.

Authors:  Michela Giannecchini; Marco Matteucci; Rossana Pesi; Francesco Sgarrella; Maria Grazia Tozzi; Marcella Camici
Journal:  Int J Biochem Cell Biol       Date:  2005-04       Impact factor: 5.085

2.  Cost of disorders of the brain in Europe.

Authors:  Patrik Andlin-Sobocki; Bengt Jönsson; Hans-Ulrich Wittchen; Jes Olesen
Journal:  Eur J Neurol       Date:  2005-06       Impact factor: 6.089

3.  Effect of inosine supplementation on aerobic and anaerobic cycling performance.

Authors:  R D Starling; T A Trappe; K R Short; M Sheffield-Moore; A C Jozsi; W J Fink; D L Costill
Journal:  Med Sci Sports Exerc       Date:  1996-09       Impact factor: 5.411

4.  Purine nucleotide metabolism in resident and activated rat macrophages in vitro.

Authors:  J Barankiewicz; A Cohen
Journal:  Eur J Immunol       Date:  1985-06       Impact factor: 5.532

5.  High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system.

Authors:  D F Martins; L Mazzardo-Martins; F Soldi; J Stramosk; A P Piovezan; A R S Santos
Journal:  Neuroscience       Date:  2013-01-03       Impact factor: 3.590

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Effects of inosine on neuronal apoptosis and the expression of cytochrome C mRNA following hypoxic-ischemic brain damage in neonatal rats.

Authors:  Yong-Hong Deng; Shou-Jin Kuang; Ming-Yan Hei; Lang Tian
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2006-08

8.  Secondary degeneration reduced by inosine after spinal cord injury in rats.

Authors:  F Liu; S-W You; L-P Yao; H-L Liu; X-Y Jiao; M Shi; Q-B Zhao; G Ju
Journal:  Spinal Cord       Date:  2005-11-29       Impact factor: 2.772

9.  Uric acid as radical scavenger and antioxidant in the heart.

Authors:  B F Becker; N Reinholz; T Ozçelik; B Leipert; E Gerlach
Journal:  Pflugers Arch       Date:  1989-11       Impact factor: 3.657

Review 10.  Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.

Authors:  C Szabó; V L Dawson
Journal:  Trends Pharmacol Sci       Date:  1998-07       Impact factor: 14.819

View more
  16 in total

1.  Glutamatergic system and mTOR-signaling pathway participate in the antidepressant-like effect of inosine in the tail suspension test.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Tanara V Peres; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  J Neural Transm (Vienna)       Date:  2017-07-10       Impact factor: 3.575

Review 2.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

3.  Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A₁ and A2A receptor activation.

Authors:  Mauricio P Cunha; Francis L Pazini; Julia M Rosa; Ana B Ramos-Hryb; Ágatha Oliveira; Manuella P Kaster; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2015-02-22       Impact factor: 3.765

4.  Protective Effects of Inosine on Memory Consolidation in a Rat Model of Scopolamine-Induced Cognitive Impairment: Involvement of Cholinergic Signaling, Redox Status, and Ion Pump Activities.

Authors:  Fernanda Cardoso Teixeira; Bruna da Silveira de Mattos; Julia Eisenhardt de Mello; Juliane Cardoso; Luiza Spohr; Karina Pereira Luduvico; Mayara Sandrielly Pereira Soares; Fabiano Barbosa Carvalho; Jessie Martins Gutierres; Anelize de Oliveira Campello Felix; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Neurochem Res       Date:  2021-10-08       Impact factor: 3.996

5.  The impact of inosine on hippocampal synaptic transmission and plasticity involves the release of adenosine through equilibrative nucleoside transporters rather than the direct activation of adenosine receptors.

Authors:  Pedro Valada; Sonja Hinz; Christin Vielmuth; Cátia R Lopes; Rodrigo A Cunha; Christa E Müller; João Pedro Lopes
Journal:  Purinergic Signal       Date:  2022-09-26       Impact factor: 3.950

6.  Signaling pathways underlying the antidepressant-like effect of inosine in mice.

Authors:  Filipe Marques Gonçalves; Vivian Binder Neis; Débora Kurrle Rieger; Mark William Lopes; Isabella A Heinrich; Ana Paula Costa; Ana Lúcia S Rodrigues; Manuella P Kaster; Rodrigo Bainy Leal
Journal:  Purinergic Signal       Date:  2016-12-13       Impact factor: 3.765

7.  Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.

Authors:  Stella Célio Junqueira; Igor Dos Santos Coelho; Vicente Lieberknecht; Mauricio Peña Cunha; João B Calixto; Ana Lúcia S Rodrigues; Adair Roberto Soares Santos; Rafael Cypriano Dutra
Journal:  Mol Neurobiol       Date:  2016-04-30       Impact factor: 5.590

8.  Inosine improves cognitive function and decreases aging-induced oxidative stress and neuroinflammation in aged female rats.

Authors:  Poonam Ruhal; Dinesh Dhingra
Journal:  Inflammopharmacology       Date:  2018-04-04       Impact factor: 4.473

9.  Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans.

Authors:  Dong Ik Park; Carine Dournes; Inge Sillaber; Manfred Uhr; John M Asara; Nils C Gassen; Theo Rein; Marcus Ising; Christian Webhofer; Michaela D Filiou; Marianne B Müller; Christoph W Turck
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

10.  Exposure of C57BL/6J mice to long photoperiod during early life stages increases body weight and alters plasma metabolomic profiles in adulthood.

Authors:  Tatsuhiro Uchiwa; Yusuke Takai; Ayako Tashiro; Mitsuhiro Furuse; Shinobu Yasuo
Journal:  Physiol Rep       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.